
|Articles|December 15, 2002
Imiquimod vs. Interferon
Paris - Imiquimod 5 percent cream (Aldara), like intralesional interferon, may prevent keloid recurrence. And although imiquimod use may necessitate longer treatment - up to eight weeks compared to two injections of interferon - the drug is without adverse systemic reactions, Ivonne Arellano, M.D., said at the World Congress of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity
2
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
3
Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026
4
FDA Feedback Supports BLA Pathway for Sonelokimab in HS
5


















